Frequency Specific Microcurrent Therapy for Mild Traumatic Brain Injury

Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · Jan 30, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a treatment called Frequency Specific Microcurrent Therapy (FSM) for people who have experienced a mild traumatic brain injury (mTBI), such as a concussion. While many individuals recover from mTBI within a week or so, some continue to have bothersome symptoms like headaches, dizziness, and trouble concentrating. The goal of this study is to see if FSM can help improve these lingering symptoms in 52 participants.

To be eligible for this trial, participants should be between the ages of 20 and 65 and have had a mild brain injury that caused a loss of consciousness for less than 30 minutes. They should also still be experiencing symptoms more than ten days after the injury. Participants will undergo assessments and use a special device during the study. It’s important to know that those with more severe injuries or certain health conditions will not be able to participate. This study is not yet recruiting participants, but it aims to find new ways to help those struggling with the effects of mild traumatic brain injuries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age between 20 and 65, inclusive, for both males and females.
• • 2. History of traumatic brain injury with a loss of consciousness lasting less than 30 minutes, initial Glasgow Coma Scale (GCS) score ranging from 13 to 15.
• • 3. Presence of persistent post-concussion symptoms starting from the day of injury and lasting for more than ten days.
• • 4. Complete consciousness or decision-making capacity at the time of enrollment.
• • 5. Brain imaging through CT or MRI indicating the absence of significant midline shift, no evident damage to the brainstem (excluding the pyramidal tract), or thalamus. Each brain lobe lesion should not exceed 30% of the respective cerebral hemisphere.
• Exclusion Criteria:
• • 1. Individuals below 20 years or above 65 years of age, regardless of gender.
• • 2. History of traumatic brain injury with a loss of consciousness exceeding 30 minutes, initial Glasgow Coma Scale (GCS) score less than 13.
• • 3. Not a first-time occurrence of traumatic brain injury.
• • 4. Brain imaging through CT or MRI revealing significant midline shift, evident damage to the brainstem or thalamus, with each brain lobe lesion exceeding 30% of the respective cerebral hemisphere.
• • 5. Presence of comorbidities such as cancer, depression.